Furthermore, knowledge of germline BRCA1/2 status in women living with ovarian cancer directly impacts first-degree relatives (FDRs), who have a 50% probability of carrying the same mutation and are yet to be diagnosed, and therefore, could also benefit from risk-reducing prevention strategies (58). This evidence concerns the gene BRCA1 and ovarian cancer.